"Immune Complex Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.
| Descriptor ID |
D007105
|
| MeSH Number(s) |
C20.543.520
|
| Concept/Terms |
Immune Complex Diseases- Immune Complex Diseases
- Disease, Immune Complex
- Diseases, Immune Complex
- Immune Complex Disease
- Type III Hypersensitivity
- Hypersensitivity, Type III
- Hypersensitivities, Type III
- Type III Hypersensitivities
|
Below are MeSH descriptors whose meaning is more general than "Immune Complex Diseases".
Below are MeSH descriptors whose meaning is more specific than "Immune Complex Diseases".
This graph shows the total number of publications written about "Immune Complex Diseases" by people in this website by year, and whether "Immune Complex Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immune Complex Diseases" by people in Profiles.
-
Late Corneal Stromal Deposits After COVID-19. Cornea. 2021 08 01; 40(8):1067-1069.
-
A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms. Inflammopharmacology. 2020 Oct; 28(5):1219-1222.
-
Antibody-dependent enhancement and COVID-19: Moving toward acquittal. Clin Immunol. 2020 08; 217:108496.
-
A plea for the pathogenic role of immune complexes in severe Covid-19. Clin Immunol. 2020 08; 217:108493.
-
Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020 08; 217:108487.
-
COVID-19 type III hypersensitivity reaction. Med Hypotheses. 2020 07; 140:109763.
-
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria. J Dtsch Dermatol Ges. 2018 Apr; 16(4):477-478.
-
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. J Am Soc Nephrol. 2018 01; 29(1):283-294.
-
Some aspects of humoral and cellular immunity in naturally occuring feline infectious peritonitis. Vet Immunol Immunopathol. 1998 Oct 23; 65(2-4):205-20.